Literature DB >> 3264256

Effects of epidermal growth factor and insulin-like growth factor I on the levels of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells.

M P Steinkampf1, C R Mendelson, E R Simpson.   

Abstract

The effects of growth factors to regulate the activity of aromatase, as well as the synthesis of aromatase cytochrome P-450 (P-450AROM) have been studied in human ovarian granulosa cells obtained from women undergoing oocyte retrieval. Insulin-like growth factor I (IGF-I) increased aromatase activity as well as the synthesis of P-450AROM, in a concentration-dependent fashion. The levels of hybridizable mRNA species encoding cytochrome P-450AROM were also increased with IGF-I treatment. By contrast, epidermal growth factor (EGF) had no effect on these parameters when added alone, but markedly inhibited the action of follicle-stimulating hormone (FSH) to stimulate aromatase activity, and the synthesis of cytochrome P-450AROM, as well as its ability to increase the levels of mRNA encoding the enzyme. It is concluded that these growth factors have opposite effects on aromatase activity, and that these actions reflect, in part, changes in the synthesis of cytochrome P-450AROM, which in turn are the consequence of changes in the levels of mRNA encoding this enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264256     DOI: 10.1016/0303-7207(88)90199-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Characterization of aromatase cytochrome P-450 mRNA in rat perinatal brain, ovary and a Leydig tumor cell line: evidence for the existence of brain specific aromatase transcripts.

Authors:  E D Lephart; M A Herbst; M J McPhaul
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

3.  Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J A Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2015-06-30       Impact factor: 5.958

4.  Tumor necrosis factor alpha inhibition of follicle-stimulating hormone-induced granulosa cell estradiol secretion in the human does not involve reduction of cAMP secretion but inhibition at post-cAMP site(s).

Authors:  V Montgomery Rice; S D Limback; K F Roby; P F Terranova
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.633

5.  Influence of Insulin-Like Growth Factor-I on Maturation and Fertilization Rate of Immature Oocyte and Embryo Development in NMRI Mouse with TCM199 and α-MEM Medium.

Authors:  Mehdi Akbartabar Toori; Esmaeil Mosavi; Mohsen Nikseresht; Mehrzad Jafari Barmak; Reza Mahmoudi
Journal:  J Clin Diagn Res       Date:  2014-12-05

6.  Effects of IGF-1 on the Three-Dimensional Culture of Ovarian Preantral Follicles and Superovulation Rates in Mice.

Authors:  Shizhen Dai; Hanxue Zhang; Feng Yang; Wei Shang; Shenming Zeng
Journal:  Biology (Basel)       Date:  2022-05-29

7.  The effect of epidermal growth factor in human granulosa cells varies with follicle size.

Authors:  B S Hurst; H A Zacur; W D Schlaff; M D Damewood; G D Berkovitz
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

8.  Use of granulosa-luteal cell culture to evaluate low and high clinical responses to menotropin stimulation.

Authors:  B S Hurst; H A Zacur; W D Schlaff; G D Berkovitz
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

Review 9.  Aromatase expression in the ovary: hormonal and molecular regulation.

Authors:  Carlos Stocco
Journal:  Steroids       Date:  2008-02-01       Impact factor: 2.668

10.  Synergistic effect of fadrozole and insulin-like growth factor-I on female-to-male sex reversal and body weight of broiler chicks.

Authors:  Mohammad Mohammadrezaei; Majid Toghyani; Abbasali Gheisari; Mehdi Toghyani; Shahin Eghbalsaied
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.